Pitfalls in RECIST Data Extraction for Clinical Trials: Beyond the Basics

Richard G. Abramson, Carrie R. McGhee, Nikita Lakomkin, Carlos L. Arteaga

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Response Evaluation Criteria in Solid Tumors (RECIST) is a standardized methodology for determining therapeutic response to anticancer therapy using changes in lesion appearance on imaging studies. Many radiologists are now using RECIST in their routine clinical workflow, as part of consultative arrangements, or within dedicated imaging core laboratories. Although basic RECIST methodology is well described in published articles and online resources, inexperienced readers may encounter difficulties with certain nuances and subtleties of RECIST. This article illustrates a set of pitfalls in RECIST assessment considered to be "beyond the basics." These pitfalls were uncovered during a quality improvement review of a recently established cancer imaging core laboratory staffed by radiologists with limited prior RECIST experience. Pitfalls are presented in four categories: (1) baseline selection of lesions, (2) reassessment of target lesions, (3) reassessment of nontarget lesions, and (4) identification of new lesions. Educational and operational strategies for addressing these pitfalls are suggested. Attention to these pitfalls and strategies may improve the overall quality of RECIST assessments performed by radiologists.

Original languageEnglish (US)
Pages (from-to)779-786
Number of pages8
JournalAcademic Radiology
Volume22
Issue number6
DOIs
StatePublished - Jan 1 2015

Fingerprint

Clinical Trials
Workflow
Quality Improvement
Response Evaluation Criteria in Solid Tumors
Therapeutics
Radiologists
Neoplasms

Keywords

  • Antitumor efficacy
  • Oncology
  • RECIST
  • Solid malignancies
  • Tumor response assessment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Pitfalls in RECIST Data Extraction for Clinical Trials : Beyond the Basics. / Abramson, Richard G.; McGhee, Carrie R.; Lakomkin, Nikita; Arteaga, Carlos L.

In: Academic Radiology, Vol. 22, No. 6, 01.01.2015, p. 779-786.

Research output: Contribution to journalReview article

Abramson, Richard G. ; McGhee, Carrie R. ; Lakomkin, Nikita ; Arteaga, Carlos L. / Pitfalls in RECIST Data Extraction for Clinical Trials : Beyond the Basics. In: Academic Radiology. 2015 ; Vol. 22, No. 6. pp. 779-786.
@article{b78157005ff5402f8d695e75f94d4e9e,
title = "Pitfalls in RECIST Data Extraction for Clinical Trials: Beyond the Basics",
abstract = "Response Evaluation Criteria in Solid Tumors (RECIST) is a standardized methodology for determining therapeutic response to anticancer therapy using changes in lesion appearance on imaging studies. Many radiologists are now using RECIST in their routine clinical workflow, as part of consultative arrangements, or within dedicated imaging core laboratories. Although basic RECIST methodology is well described in published articles and online resources, inexperienced readers may encounter difficulties with certain nuances and subtleties of RECIST. This article illustrates a set of pitfalls in RECIST assessment considered to be {"}beyond the basics.{"} These pitfalls were uncovered during a quality improvement review of a recently established cancer imaging core laboratory staffed by radiologists with limited prior RECIST experience. Pitfalls are presented in four categories: (1) baseline selection of lesions, (2) reassessment of target lesions, (3) reassessment of nontarget lesions, and (4) identification of new lesions. Educational and operational strategies for addressing these pitfalls are suggested. Attention to these pitfalls and strategies may improve the overall quality of RECIST assessments performed by radiologists.",
keywords = "Antitumor efficacy, Oncology, RECIST, Solid malignancies, Tumor response assessment",
author = "Abramson, {Richard G.} and McGhee, {Carrie R.} and Nikita Lakomkin and Arteaga, {Carlos L.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.acra.2015.01.015",
language = "English (US)",
volume = "22",
pages = "779--786",
journal = "Academic Radiology",
issn = "1076-6332",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Pitfalls in RECIST Data Extraction for Clinical Trials

T2 - Beyond the Basics

AU - Abramson, Richard G.

AU - McGhee, Carrie R.

AU - Lakomkin, Nikita

AU - Arteaga, Carlos L.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Response Evaluation Criteria in Solid Tumors (RECIST) is a standardized methodology for determining therapeutic response to anticancer therapy using changes in lesion appearance on imaging studies. Many radiologists are now using RECIST in their routine clinical workflow, as part of consultative arrangements, or within dedicated imaging core laboratories. Although basic RECIST methodology is well described in published articles and online resources, inexperienced readers may encounter difficulties with certain nuances and subtleties of RECIST. This article illustrates a set of pitfalls in RECIST assessment considered to be "beyond the basics." These pitfalls were uncovered during a quality improvement review of a recently established cancer imaging core laboratory staffed by radiologists with limited prior RECIST experience. Pitfalls are presented in four categories: (1) baseline selection of lesions, (2) reassessment of target lesions, (3) reassessment of nontarget lesions, and (4) identification of new lesions. Educational and operational strategies for addressing these pitfalls are suggested. Attention to these pitfalls and strategies may improve the overall quality of RECIST assessments performed by radiologists.

AB - Response Evaluation Criteria in Solid Tumors (RECIST) is a standardized methodology for determining therapeutic response to anticancer therapy using changes in lesion appearance on imaging studies. Many radiologists are now using RECIST in their routine clinical workflow, as part of consultative arrangements, or within dedicated imaging core laboratories. Although basic RECIST methodology is well described in published articles and online resources, inexperienced readers may encounter difficulties with certain nuances and subtleties of RECIST. This article illustrates a set of pitfalls in RECIST assessment considered to be "beyond the basics." These pitfalls were uncovered during a quality improvement review of a recently established cancer imaging core laboratory staffed by radiologists with limited prior RECIST experience. Pitfalls are presented in four categories: (1) baseline selection of lesions, (2) reassessment of target lesions, (3) reassessment of nontarget lesions, and (4) identification of new lesions. Educational and operational strategies for addressing these pitfalls are suggested. Attention to these pitfalls and strategies may improve the overall quality of RECIST assessments performed by radiologists.

KW - Antitumor efficacy

KW - Oncology

KW - RECIST

KW - Solid malignancies

KW - Tumor response assessment

UR - http://www.scopus.com/inward/record.url?scp=84929043359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929043359&partnerID=8YFLogxK

U2 - 10.1016/j.acra.2015.01.015

DO - 10.1016/j.acra.2015.01.015

M3 - Review article

C2 - 25794800

AN - SCOPUS:84929043359

VL - 22

SP - 779

EP - 786

JO - Academic Radiology

JF - Academic Radiology

SN - 1076-6332

IS - 6

ER -